Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Smith

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphomaRoberto Rodriguez, Auayporn Nademanee, Nora Ruel, et al.
Molecular Cancer Therapeutics|October 8, 2009
Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylatorsWilliam R Wilson, Stephen M Stribbling, Frederik B Pruijn, et al.
Journal of Medicinal Chemistry|November 3, 2009
Hypoxia-activated prodrugs: substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) prodrugs of DNA minor groove alkylating agentsMoana Tercel, Graham J Atwell, Shangjin Yang, et al.
Bone Marrow Transplantation|April 20, 2022
Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host diseaseAmandeep Salhotra, Min Talley, Xiwei Wu, et al.
Open Forum Infectious Diseases|August 13, 2024
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold InfectionJustine Abella Ross, Brian Lee, Huiyan Ma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphomaHenry C Fung, Patrick Stiff, Jeff Schriber, et al.
Blood|December 8, 2009
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimensRoberto Rodriguez, Ryotaro Nakamura, Joycelynne M Palmer, et al.
Cold Spring Harbor Perspectives in Medicine|March 11, 2020
Non-Hodgkin Lymphomas: Malignancies Arising from Mature B CellsJennifer Shingleton, Jie Wang, Carolyn Baloh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2020
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic LeukemiaMatthew Mei, Ni-Chun Tsai, Sally Mokhtari, et al.
Bone Marrow Transplantation|December 16, 2022
Association of pre-transplant vancomycin resistant enterococcus colonization status on long-term outcomes of allogeneic-hematopoietic cell transplantationAmandeep Salhotra, Karamjeet S Sandhu, Dongyun Yang, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphomaRoberto Rodriguez, Auayporn Nademanee, Nora Ruel, et al.
Molecular Cancer Therapeutics|October 8, 2009
Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylatorsWilliam R Wilson, Stephen M Stribbling, Frederik B Pruijn, et al.
Journal of Medicinal Chemistry|November 3, 2009
Hypoxia-activated prodrugs: substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) prodrugs of DNA minor groove alkylating agentsMoana Tercel, Graham J Atwell, Shangjin Yang, et al.
Bone Marrow Transplantation|April 20, 2022
Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host diseaseAmandeep Salhotra, Min Talley, Xiwei Wu, et al.
Open Forum Infectious Diseases|August 13, 2024
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold InfectionJustine Abella Ross, Brian Lee, Huiyan Ma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphomaHenry C Fung, Patrick Stiff, Jeff Schriber, et al.
Blood|December 8, 2009
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimensRoberto Rodriguez, Ryotaro Nakamura, Joycelynne M Palmer, et al.
Cold Spring Harbor Perspectives in Medicine|March 11, 2020
Non-Hodgkin Lymphomas: Malignancies Arising from Mature B CellsJennifer Shingleton, Jie Wang, Carolyn Baloh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2020
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic LeukemiaMatthew Mei, Ni-Chun Tsai, Sally Mokhtari, et al.
Bone Marrow Transplantation|December 16, 2022
Association of pre-transplant vancomycin resistant enterococcus colonization status on long-term outcomes of allogeneic-hematopoietic cell transplantationAmandeep Salhotra, Karamjeet S Sandhu, Dongyun Yang, et al.
Pageof 5